metoprolol has been researched along with Central Nervous System Origin Vertigo in 1 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Adults aged 18 years or above diagnosed with probable or definitive VM according to the Neuhauser criteria 2001 were randomly assigned 1:1 to 6 months blinded metoprolol (maintenance dosage of 95 mg daily) or placebo." | 2.90 | Results and lessons learnt from a randomized controlled trial: prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG). ( Adrion, C; Al Tawil, A; Bayer, O; Mansmann, U; Strupp, M, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayer, O | 1 |
| Adrion, C | 1 |
| Al Tawil, A | 1 |
| Mansmann, U | 1 |
| Strupp, M | 1 |
1 trial available for metoprolol and Central Nervous System Origin Vertigo
| Article | Year |
|---|---|
Results and lessons learnt from a randomized controlled trial: prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG).
Topics: Adult; Aged; Dizziness; Double-Blind Method; Early Termination of Clinical Trials; Female; Follow-Up | 2019 |